The company’s haematologic oncology portfolio generated $1.42bn in global net re...
The collaboration will combine Generate Biomedicines’ capabilities with MD Ander...
Tavros will gain the right to access OpenBench’s proprietary artificial intellig...
The company will use a portion of the funds to transition its first-in-class inv...
Abilify Asimtufii is a long-acting, extended-release injectable suspension offer...
Increased drug shortages, exposure of supply chain vulnerabilities by Covid-19, ...
Originally granted approval in the US, in 2017, Ozempic has subsequently obtaine...
The OCU410ST is intended for the treatment of ABCA4-linked retinopathies.
Research company ranked in the Business Expansion and Research and Development c...
The CRISPR-based gene therapy received the designation from the US FDA for the s...
DNA sequencing machines have typically been designated for “research use only,” ...
The Biden administration rolled out proposals to set national standards for care...
Is a specter haunting Europe? Will Eli Lilly usurp Johnson & Johnson? And what d...
An international research collaboration is revealing how genetics shapes human h...
In the latest edition of STAT's Health Tech newsletter: GoodRx hires former tech...
STAT sits down for a conversation with past all-star Wunderkinds to see where th...
